165 related articles for article (PubMed ID: 32470544)
1. Type I interferon-independent T cell impairment in a Tmem173 N153S/WT mouse model of STING associated vasculopathy with onset in infancy (SAVI).
Siedel H; Roers A; Rösen-Wolff A; Luksch H
Clin Immunol; 2020 Jul; 216():108466. PubMed ID: 32470544
[TBL] [Abstract][Full Text] [Related]
2. STING-associated lung disease in mice relies on T cells but not type I interferon.
Luksch H; Stinson WA; Platt DJ; Qian W; Kalugotla G; Miner CA; Bennion BG; Gerbaulet A; Rösen-Wolff A; Miner JJ
J Allergy Clin Immunol; 2019 Jul; 144(1):254-266.e8. PubMed ID: 30772497
[TBL] [Abstract][Full Text] [Related]
3. Hierarchy of clinical manifestations in SAVI N153S and V154M mouse models.
Motwani M; Pawaria S; Bernier J; Moses S; Henry K; Fang T; Burkly L; Marshak-Rothstein A; Fitzgerald KA
Proc Natl Acad Sci U S A; 2019 Apr; 116(16):7941-7950. PubMed ID: 30944222
[TBL] [Abstract][Full Text] [Related]
4. The common
Aybar-Torres A; Saldarriaga LA; Pham AT; Emtiazjoo AM; Sharma AK; Bryant AJ; Jin L
bioRxiv; 2024 Mar; ():. PubMed ID: 37886547
[TBL] [Abstract][Full Text] [Related]
5. STING-associated vasculopathy develops independently of IRF3 in mice.
Warner JD; Irizarry-Caro RA; Bennion BG; Ai TL; Smith AM; Miner CA; Sakai T; Gonugunta VK; Wu J; Platt DJ; Yan N; Miner JJ
J Exp Med; 2017 Nov; 214(11):3279-3292. PubMed ID: 28951494
[TBL] [Abstract][Full Text] [Related]
6. A Human Gain-of-Function STING Mutation Causes Immunodeficiency and Gammaherpesvirus-Induced Pulmonary Fibrosis in Mice.
Bennion BG; Ingle H; Ai TL; Miner CA; Platt DJ; Smith AM; Baldridge MT; Miner JJ
J Virol; 2019 Feb; 93(4):. PubMed ID: 30463976
[TBL] [Abstract][Full Text] [Related]
7. Severe combined immunodeficiency in stimulator of interferon genes (STING) V154M/wild-type mice.
Bouis D; Kirstetter P; Arbogast F; Lamon D; Delgado V; Jung S; Ebel C; Jacobs H; Knapp AM; Jeremiah N; Belot A; Martin T; Crow YJ; André-Schmutz I; Korganow AS; Rieux-Laucat F; Soulas-Sprauel P
J Allergy Clin Immunol; 2019 Feb; 143(2):712-725.e5. PubMed ID: 29800647
[TBL] [Abstract][Full Text] [Related]
8. The IFN-γ receptor promotes immune dysregulation and disease in STING gain-of-function mice.
Stinson WA; Miner CA; Zhao FR; Lundgren AJ; Poddar S; Miner JJ
JCI Insight; 2022 Sep; 7(17):. PubMed ID: 36073546
[TBL] [Abstract][Full Text] [Related]
9. Lung Inflammation in STING-Associated Vasculopathy with Onset in Infancy (SAVI).
David C; Frémond ML
Cells; 2022 Jan; 11(3):. PubMed ID: 35159128
[TBL] [Abstract][Full Text] [Related]
10. The activity of disease-causative STING variants can be suppressed by wild-type STING through heterocomplex formation.
Shindo R; Kuchitsu Y; Mukai K; Taguchi T
Front Cell Dev Biol; 2022; 10():1037999. PubMed ID: 36438571
[TBL] [Abstract][Full Text] [Related]
11. Disease-associated mutations identify a novel region in human STING necessary for the control of type I interferon signaling.
Melki I; Rose Y; Uggenti C; Van Eyck L; Frémond ML; Kitabayashi N; Rice GI; Jenkinson EM; Boulai A; Jeremiah N; Gattorno M; Volpi S; Sacco O; Terheggen-Lagro SWJ; Tiddens HAWM; Meyts I; Morren MA; De Haes P; Wouters C; Legius E; Corveleyn A; Rieux-Laucat F; Bodemer C; Callebaut I; Rodero MP; Crow YJ
J Allergy Clin Immunol; 2017 Aug; 140(2):543-552.e5. PubMed ID: 28087229
[TBL] [Abstract][Full Text] [Related]
12. Expression of a constitutively active human
Martin GR; Henare K; Salazar C; Scheidl-Yee T; Eggen LJ; Tailor PP; Kim JH; Podstawka J; Fritzler MJ; Kelly MM; Yipp BG; Jirik FR
Life Sci Alliance; 2019 Jun; 2(3):. PubMed ID: 31221625
[TBL] [Abstract][Full Text] [Related]
13. Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 Patients.
Frémond ML; Hadchouel A; Berteloot L; Melki I; Bresson V; Barnabei L; Jeremiah N; Belot A; Bondet V; Brocq O; Chan D; Dagher R; Dubus JC; Duffy D; Feuillet-Soummer S; Fusaro M; Gattorno M; Insalaco A; Jeziorski E; Kitabayashi N; Lopez-Corbeto M; Mazingue F; Morren MA; Rice GI; Rivière JG; Seabra L; Sirvente J; Soler-Palacin P; Stremler-Le Bel N; Thouvenin G; Thumerelle C; Van Aerde E; Volpi S; Willcocks S; Wouters C; Breton S; Molina T; Bader-Meunier B; Moshous D; Fischer A; Blanche S; Rieux-Laucat F; Crow YJ; Neven B
J Allergy Clin Immunol Pract; 2021 Feb; 9(2):803-818.e11. PubMed ID: 33217613
[TBL] [Abstract][Full Text] [Related]
14. Radioresistant cells initiate lymphocyte-dependent lung inflammation and IFNγ-dependent mortality in STING gain-of-function mice.
Gao KM; Motwani M; Tedder T; Marshak-Rothstein A; Fitzgerald KA
Proc Natl Acad Sci U S A; 2022 Jun; 119(25):e2202327119. PubMed ID: 35696583
[TBL] [Abstract][Full Text] [Related]
15. Type 1 interferonopathy presenting as juvenile idiopathic arthritis with interstitial lung disease: report of a new phenotype.
Clarke SLN; Robertson L; Rice GI; Seabra L; Hilliard TN; Crow YJ; Ramanan AV
Pediatr Rheumatol Online J; 2020 May; 18(1):37. PubMed ID: 32398023
[TBL] [Abstract][Full Text] [Related]
16. A rare manifestation of STING-associated vasculopathy with onset in infancy: a case report.
Weidler S; Koss S; Wolf C; Lucas N; Brunner J; Lee-Kirsch MA
Pediatr Rheumatol Online J; 2024 Jan; 22(1):9. PubMed ID: 38178067
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic spectrum in recessive STING-associated vasculopathy with onset in infancy: Four novel cases and analysis of previously reported cases.
Wan R; Fänder J; Zakaraia I; Lee-Kirsch MA; Wolf C; Lucas N; Olfe LI; Hendrich C; Jonigk D; Holzinger D; Steindor M; Schmidt G; Davenport C; Klemann C; Schwerk N; Griese M; Schlegelberger B; Stehling F; Happle C; Auber B; Steinemann D; Wetzke M; von Hardenberg S
Front Immunol; 2022; 13():1029423. PubMed ID: 36275728
[TBL] [Abstract][Full Text] [Related]
18. Human induced pluripotent stem cells generated from STING-associated vasculopathy with onset in infancy (SAVI) patients with a heterozygous mutation in the STING gene.
Mehta A; Yu Q; Liu Y; Yang D; Zou J; Beers J; de Jesus Rasheed AA; Rastegar AT; Goldbach-Mansky R; Boehm M; Chen G
Stem Cell Res; 2022 Dec; 65():102974. PubMed ID: 36399927
[TBL] [Abstract][Full Text] [Related]
19. Case report: JAK1/2 inhibition with baricitinib in the treatment of STING-associated vasculopathy with onset in infancy.
Wu J; Zhou Q; Zhou H; Lu M
Pediatr Rheumatol Online J; 2023 Oct; 21(1):131. PubMed ID: 37884945
[TBL] [Abstract][Full Text] [Related]
20. A Novel Biallelic
Alghamdi MA; Mulla J; Saheb Sharif-Askari N; Guzmán-Vega FJ; Arold ST; Abd-Alwahed M; Alharbi N; Kashour T; Halwani R
Front Immunol; 2020; 11():599564. PubMed ID: 33488593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
